Answers are grounded in this paper and cite their sources.
Serial sIL‐2R serum levels were evaluated as an indicator of cytomegalovirus infection and response to antiviral therapy. All cases of post‐transplant CMV infection or disease were studied over a 2.5‐year period with serial sIL‐2R serum levels monitored daily post‐transplant until discharge, during each inpatient admission and with each outpatient laboratory analysis. Mean sIL‐2 levels±S.E.M. rose from a baseline level of 3662+321 U/ml to 11657±3311 U/ml at the time of diagnosis. Serum SIL‐2R concentrations were significantly elevated from baseline as early as 14 days prior to diagnosis of CMV. Mean peak sIL‐2R levels occurred an average of 4 days after the initiation of ganciclovir therapy and remained significantly elevated for an average of 20 days of treatment. Serum sIL‐ 2R levels in patients with resolved CMV returned to within 20% of baseline after 20 days of therapy. These data support the idea that serial monitoring of SIL‐2R serum levels may be useful adjunctively in the diagnosis of CMV as well as determining the response to and duration of antiviral therapy.
No takes yet. Share an insight, caveat, or question.
Rossi et al. (1996) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: